Merck's RSV antibody for infants effective in reducing some types of infections in study
Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some ...
Why This Pharma Boss Isn’t Chasing the Obesity Hype
Belen Garijo, the CEO of Merck KGaA, says focus on growth and innovation is key to the German group’s future.
Germany's Merck open to more M&A for its Life Science division
German science and technology group Merck is open to more acquisitions for its Life Science business after announcing in May ...
Merck & Co., Inc. (MRK): Among the Blue Chip Stocks With Low PE Ratios
We recently compiled a list of the 7 Blue Chip Stocks with Low PE Ratios. In this article, we are going to take a look at ...
Barchart on MSN1d
Here's What to Expect From Merck & Co.'s Next Earnings Report
Merck & Co., Inc. (MRK), headquartered in Rahway, New Jersey, is a major player in healthcare. Specializing in ...
BioSpace3h
Merck, Pfizer Tout Promising Respective Data in RSV With High Rates of Prevention
Merck’s investigational antibody clesrovimab demonstrated more than 60% effectiveness in reducing some types of respiratory ...
Merck KGaA Shares Jump on Expectations of AI Boost
The German company said booming artificial-intelligence demand would help its electronics sales grow faster than previously ...
Merck KGaA Cuts Medium-Term Healthcare, Life-Science Outlook but Lifts Electronics Guidance
Merck KGaA lowered its medium-term outlook for its healthcare and life-science segment due to China challenges and recent ...
FiercePharma10d
Merck's Keytruda stages comeback in head and neck cancer with trial win in earlier-stage disease
Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...
Business Wire18h
Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease …
Clesrovimab (MK-1654), an Investigational RSV Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and ...
Merck Is At Support And Should Go Higher (Technical Analysis)
Merck's recent decline is due to reduced profit guidance and FDA decisions, but shares are at a support level. Read why I ...
C&EN1d
Merck & Co. hosts 2024 Pharma Leaders Conference
On Oct. 1 and 2, the American Chemical Society held its 21st annual Pharma Leaders Conference, hosted this year at the Merck & Co. campus in Rahway, New Jersey. Leaders in medicinal chemistry from ...